APC (Recent Decisions)

APC Recent Decisions March 2022

otigo otitis media phenazone hayfever allergic rhinitis allergy rifaximin denosumab prolia osteoporosis alprostadil aviptadil phentolamine invicorp vitaros edoxaban liothyronine T3 thyroid

APC Recent Decisions February 2022

Tolterodine trospium inclisiran HRT bimekizumab epistatus midazolam co-enzyme Q10 ubidecarenone ubiquinone rivaroxaban Xarelto paxlovid ciprofloxacin eardrops diprobase limbo sealtight waterproof

APC Recent Decisions November 2021

midazolam buccal oromucosal epistatus buccolam status epilepticus methenamine hiprex levofloxacin dapagliflozin forxiga indocyanine shortage environment blueteq device

APC Recent Decisions October 2021

Inclisiran Postural hypotention acne vulgaris trimethoprim benzoyl peroxide/clindamycin azelaic acid cream testosterone menopause melotoinin cluster headaches donepezil dantrolene emerade diazepam ivermectin

APC Recent Decisions September 2021

Bempedoic inclisiran lipid statin c.diff fidaxomicin trurapi aspart casirivimab imdevimab ronapreve varicella shingrix methoxyflurane penthrox pilocarpine oxetacaine bydureon biologics ulcerative colitis rheumatoid arthritis

APC Recent Decisions August 2021

testosterone HRT libido menopause tostran testogel somatropin growth hormone benzbromarone trimbow cavilon barrier cream barrier prasterone intrarosa blissel varenicline champix monitoring

APC Recent Decisions July 2021

chloramphenicol ferric maltol feraccru iron bempedoic bempedoic acid nilemdo calcium folinate flupentixol decanoate depixol psytixol benralizumab erenumab filgotinib anakinra andexanet